Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.24
+0.10 (1.63%)
At close: Mar 3, 2026, 4:00 PM EST
6.26
+0.02 (0.32%)
After-hours: Mar 3, 2026, 6:27 PM EST
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $396.26 million as of March 3, 2026. Its market cap has decreased by -0.09% in one year.
Market Cap
396.26M
Enterprise Value
252.15M
1-Year Change
-0.09%
Ranking
Category
Stock Price
$6.24
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $396.26M, a decrease of -0.37%. That is a compound annual growth rate of -0.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 389.91M | 12.66% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 409.46M |
| Armata Pharmaceuticals | 405.75M |
| PureTech Health | 402.16M |
| Cybin | 400.04M |
| Upstream Bio | 398.80M |
| Ginkgo Bioworks Holdings | 392.03M |
| Absci | 390.97M |
| Niagen Bioscience | 390.43M |